ClinConnect ClinConnect Logo
Search / Trial NCT06208319

Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 4, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Artificial Intelligence Colposcopy Machine Learning Algorithm Papillomavirus Cervical Cancer

ClinConnect Summary

This clinical trial is looking at a new tool that uses artificial intelligence (AI) to help doctors better understand images taken during a procedure called colposcopy, which is used to check for changes in the cervix that could lead to cervical cancer. The goal is to create an algorithm, which is a kind of computer program, that can analyze these images and provide support to doctors when they are diagnosing patients. The study will compare the AI's results with the opinions of experienced doctors to see how well it works.

To be part of this trial, you need to be a woman aged 65 to 74 who has had a colposcopy with biopsies at a specific hospital between September 2022 and December 2023. You should also have a clear reason for why you had the colposcopy and have had your biopsy results determined. Additionally, the study requires that images from your colposcopy procedure are available. One important thing to note is that participants must be fluent in French, as the study will be conducted in that language. If you join the study, you can expect to contribute to important research that could improve the way cervical health is monitored in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patients who underwent colposcopy with directed biopsies at La Pitié-Salpêtrière between September 1, 2022 and December 31, 2023
  • 2. Known clinical context (why the patient underwent colposcopy)
  • 3. Histological results of cervical biopsies (+/- conization or even hysterectomy) known
  • 4. Images available (photographs of the cervix without preparation, after application of acetic acid and after application of lugol)
  • 5. Informed of the study and not opposing the use of their data
  • Exclusion Criteria:
  • Patients who do not speak French

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported